INVA Innoviva Inc

USD 18.28 +0.01 ( +0.05%)
Icon

Innoviva Inc (INVA) Financial Statements

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 18.28

+0.01 (+0.05%)

USD 1.11B

0.75M

USD 55.00(+200.88%)

USD 20.00 (+9.41%)

Icon

INVA

Innoviva Inc (USD)
COMMON STOCK | NSD
USD 18.28
+0.01 ( +0.05%)

Innoviva Inc (INVA) Annual Income Statement (USD)

INVA Quarterly Financials (USD)

Frequently Asked Questions About Innoviva Inc (INVA) Stock

Innoviva Inc's (INVA) last reported annual revenue was USD 358.71 Million.

Innoviva Inc's (INVA) annual revenue growth rate based on the revenue reported in the past 5 years is : 6.57%

Innoviva Inc's(INVA) is profitable as of its last reported annual financials.

The net profit margin for Innoviva Inc's(INVA) from its laster reported year is 6.52%

The return on equity (ROE) for Innoviva Inc's(INVA) from its last reported annual financials is : 3.43%

The return on assets (ROA) for Innoviva Inc's(INVA) from its last reported annual financials is : 8.88%

The return on invested capital (ROIC) for Innoviva Inc's(INVA) from its last reported annual financials is : 19.05%

The Debt to Equity ratio for Innoviva Inc's(INVA) from its last reported annual financials is : 37.08%

The dividend yield for Innoviva Inc's(INVA) from its laster reported year is 0.00%

Innoviva Inc's(INVA) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...